17
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of the efficiency of DTPA and other new chelating agents for removing neptunium from target organs

Pages 613-621 | Published online: 03 Jul 2009

References

  • BAKER, E. N., 1994, Structure and reactivity of transferrins. Advances in Inorganic Chemistry, 41, 389–463.
  • BHATTACHARYYA, M. H., BREITENSTEIN, B. D., METIV1ER, H., MUGGENBURG, B. A., STRADLING, G. N. and VOLE, V, 1992, Guidebook for the treatment of accidental internal radionuclide contamination of workers. Radiation Protection D osimetry, 41, 1–49.
  • DURBIN, P. W., KuLLGREN, B., XU, J. and RAYMOND, K. N., 1994, In vivo chelation of Am(111), Pu(IV), Np(V) and U(VI) in mice by Tren-(Me-3,2-HOP0). Radiation Protection D osimetry, 53, 305–309.
  • FERNANDEZ, J. M., SCHNELLE, R. R. and DEFAYE, J.7 1995, Stereos elective synthesis of di-O-fructopyranose 1,2':2,1'-dianhydride, a spirodioxanyl pseudodisaccharide with metal cation complexing properties. Tetrahedron, 6, 307–312.
  • FISHER, R. A., 1954, Statistical Methods for Research Workers (New York: Hafner).
  • FOREMAN, H., 1962, Studies on the mechanism of plutonium uptake by bone. Health Physics, 8, 713–716.
  • FRITSCH, P., BEAUVALLET, M., JOUNIAUX, B., MOUTAIROU, K., METIVIER, H. and MASSE, R., 1987, Effects of the chem-ical form and valency states of neptunium on its jejunal transfer in the rat. International Journal of Radiation Biology, 52, 505–515.
  • FRITSCH, P., LEPAGE, M., GERASIMO, P., DUSERRE, C. and METIVIER, H., 1989, Histopathology of kidney induced by LICAM(C) therapy in baboons after inhalation of plutonium-tributylphosphate complex. Radiation Protection D osimetry, 26, 365–368.
  • GERASIMO, P., DUSERRE, C., BURGADA, R., LEROUX, Y. and METIVIER, H., 1986, Decorporation efficiency of some diphosphonates. E ulep Newsletters, 42, 63–66.
  • GRAY, S. A., STRADLING, G. N., PEARCE, M. J., WILSON, I., MOODY, J. C., BURGADA, R., DURBIN, P. W. and RAYMOND, K. N., 1994, Removal of plutonium and americium from the rat using 3,4,3-LIHOPO and DTPA after simulated wound contamination: effect of delayed administration and mass of plutonium. Radiation Protection D osimetry, 53, 319–322.
  • HAFEZ, M. B., 1968, Contribution J. l'étude du cerium et des uranides par l'acide diethylenetria mine pentaacétique (DTPA) (CEA) CEA-R-3521, p.1
  • ICRP, 1975, Report on the Task Group on Reference Man. ICRP Publication 23 (Oxford: Pergamon).
  • KONTOGHIORGHES, G. J.7 1987, Decrease solubilisation of ferritin iron and fresh iron(III) precipitate following repeated chelator treatments. Inorganica at Chimica Acta, 138, 35–39.
  • LOWRY, 0. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin phenol reagent. Journal of B io logical Chemistry, 193, 265–276.
  • MLTIVIER, H., MASSE, R., DURBIN, P. W. and RAYMOND, K. N., 1985, Promotion by tetrameric catechoylamide ligands and CaNa3-DTPA of the dissociation in vitro of the Pu—Transferrin complex formed after intravenous injec-tion of Pu-tri-N-butylphosphate. Health Physics, 49, 1302–1305.
  • MORIN, M., NENOT, J. C. and LAFUMA, J., 1973, The behavior of 237Np in the rat. Health Physics, 24, 311–315.
  • NCRP, 1980, Management of Persons Accidentally Contaminated with Radionuclides. Report no. 65 (Washington: NCRP). NENOT, J. C., LUSHBAUGH, C. C. and LINCOLN, T. A., 1978, Manual on Early Medical Treatment of Possible Radiation Injury with Appendix on Sodium Burns, Safety Series, no. 47 (Vienna: IAEA).
  • PAQUET, F., PONCY, J. L., RATEAU, G., BURGADA, R., BAILLY, T., LEROUX, Y., RAYMOND, K. N., DURBIN, P. W. and MASSE, R., 1994, Reduction of the retention of 238Pu inhaled as the tributylphosphate complex in rats treated by3,4,3-LIHOPO. Radiation Protection D osimetry, 53,323–326.
  • PAQUET, F., RAMOUNET, B., METIVIER, H. and TAYLOR, D. M., 1996, The effect of the mass and initial chemical form of neptunium on its molecular associations in blood and liver. Radiation Research, 146, 306–312.
  • PISAREVA, S. A., BELSKII, F. I., MEDVED, T. Y. and KABACHNIK, M. I.7 1987, Synthesis and complex formation properties of1,5,8,12-tetrakis(pho sp hono m ethyl)-1,5,8,12-tetraazacyclotetrad ec ane. A new cyclopendant organ-ophosphorus complexon. rzv Akad N auk S SS R, Ser Khirn, 2, 413–417.
  • SMITH, V. H., 1972, Therapeutic removal of internally deposited transuranium elements. Health Physics, 22, 765–778.
  • STEVENS, E., ROSOFF, B., WEINER, M. and SPENCER, F1.7 1962, Metabolism of the chelating agent diethylene-triamine pentaacetic acid. Proceeding of the Society of Experimental Biology and Medicine, 111, 235–238.
  • STRADLING, G. N., GRAY, S. A., MOODY, J. C., PEARCE, M. J., WILSON, I., BURGADA, R., LEROUX, Y., RAYMOND, K. N. and DURBIN, P. W., 1993, The efficacies of 3,4,3-LIHOPO and DTPA for enhancing the excretion of plutonium and americium from the rat after simulated wound contamination as nitrates. International Journal of Radiation Biology, 64, 134–140.
  • THOMPSON, R. C., 1982, Neptunium-the neglected actinide: a review of the biological and environmental literature. Radiation Research, 90, 1–32.
  • VOLE, V. and WIRTH, R., 1986, Effective chelation therapy after incorporation of neptunium-239 in rats. International Journal of Radiation Biology, 50, 955–959.
  • WIRTH, R., TAYLOR, D. M. and DUFFIELD, 41985, Identification of transferrin as the principal neptunium-binding protein in the blood serum of rats. International Journal of Nuclear and Medical Biology, 12, 327–330.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.